Kalshi and Polymarket now let you bet on drug approvals, and not everyone is thrilled about it

From Crypto Briefing

← Back to News

Crypto Briefing • July 28, 2026 at 15:20 • Analysis

The emergence of drug approval betting markets raises ethical concerns and potential regulatory challenges, impacting biotech and crypto sectors.
The post Kalshi and Polymarket now let you bet on drug approvals, and not everyone is thrilled about it appeared first on Crypto Briefing....

Read Original Article

Related Articles

Fake World Assets surpasses Collector Crypt in daily revenue just days after relaunch

Crypto Briefing • Jul 28

US senators agree on bill allowing Trump to restrict Russian energy buyers

Crypto Briefing • Jul 28

Trump backed bill could impose 100% tariffs on Russian energy buyers

Crypto Briefing • Jul 28

US goods trade deficit shrinks to $101.5B in June, but Q2 GDP growth still takes the hit

Crypto Briefing • Jul 28

Nasdaq 100 nears correction territory as AI investment doubts pile up

Crypto Briefing • Jul 28

Iran threatens European ships near Strait of Hormuz amid 2026 conflict

Crypto Briefing • Jul 28

Professional Long-Only Signals

Proprietary algorithm with high-probability entry points

80–85% signals hit take-profit without averaging

Full signals history with live proofs

Get your 14-day FREE trial

Instant delivery via Telegram • Proven performance

CAI Terminal — Multi-Account Crypto Trading Software

Windows desktop platform for Bybit subaccounts

Synchronized order execution across multiple accounts

Advanced risk control and take-profit logic

Download Professional Terminal

For crypto traders • Professional execution • Multi-account management

Instant Crypto News & Analysis

Fresh articles and intelligent market breakdowns
delivered directly to your Telegram

Join CryptoINpulse Alpha
- It's Free!